Related Experiment Video
Updated: Oct 23, 2025
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.0K
Population-Level Approaches to Preventing Type 2 Diabetes Globally
Karen R Siegel1, Ann L Albright2
1Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway Northeast, Atlanta, GA 30341, USA; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Endocrinology and Metabolism Clinics of North America
|August 17, 2021
Summary
Preventing type 2 diabetes (T2DM) requires population-level strategies targeting food and built environments, alongside social and economic factors. This review examines the evidence for these approaches to manage the T2DM epidemic.
Area of Science:
- Public Health
- Epidemiology
- Health Policy
Background:
- Type 2 diabetes (T2DM) is a growing epidemic influenced by societal factors and individual behaviors.
- Effective T2DM management necessitates a dual approach targeting both high-risk individuals and the general population.
Purpose of the Study:
- To summarize the evidence on the effectiveness and cost-effectiveness of population-level strategies for T2DM prevention.
- To identify knowledge gaps in current T2DM prevention research.
Main Methods:
- Review of existing literature on population-level T2DM prevention.
- Analysis of evidence regarding modifications to the food environment.
- Evaluation of strategies related to the built environment, physical activity, and socioeconomic factors.
Main Results:
- Evidence supports the effectiveness of modifying food and built environments for T2DM prevention.
- Population-level interventions addressing social and economic determinants show promise.
- Cost-effectiveness data varies across different intervention types.
Conclusions:
- Population-level approaches are crucial for addressing the T2DM epidemic.
- Further research is needed to optimize interventions and fill knowledge gaps.
- Integrated strategies addressing environmental and socioeconomic factors are recommended for T2DM prevention.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
01:36Carbohydrate Metabolism
12.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.7K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.9K
01:15Diabetes: Management and Pharmacotherapy
588
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
588
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
353
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
353